课题基金 / 基金详情

Development and application of nanotubes based on polytheonamides

Development and application of nanotubes based on polytheonamides
聚酰胺纳米管的开发及应用
批准号:
12556034
负责人:
MATSUNAGA Shigeki
金额:
$8.26万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

MATSUNAGA Shigeki的其他基金

相似基金

相关文献

中文摘要
翻译
在对聚酰胺的进一步结构研究中,合成了44^< >残基氨基酸的候选结构。结果表明,相关产物的结构为β,β-二甲基蛋氨酸。聚乙胺B的氧化还原反应证实了这一点。与此同时,聚酰胺A的结构被确定为非对映体,其硫原子的构型与44^< >残基不同。44^<th>残基的绝对立体化学是通过提供c端内酯的聚酰胺的BrCN反应来确定的,然后在手性固定相上进行GC分析。考察了聚酰胺的通道形成活性。聚茶酰胺A和B与细菌线状肽gramicidin A一样,均被纳入脂质双分子层并传导一价阳离子,聚茶酰胺形成的通道呈现开闭状态。这一特征的形成机制有待进一步研究。
英文摘要
In further structural study of polytheonamides, the candidates of the structures for the 44^<th> residue amino acid were synthesized. As the result, the structure of the pertinent resudue was concluded to be β,β-dimethylmethionine. This was confirmed by chemical reaction of polytheonamide B by oxidation and reduction. In the meantime, the structure of polytheonamide A was firmly established as a diastereomer differing in the configuration of the sulfur atom in the 44^<th> residue. The absolute stereochemistry of the 44^<th> residue was determined by BrCN reaction of polytheonamides affording the C-terminal lactone, and the following GC analysis on a chiral stationary phase.Channel forming activity of polytheonamides were examined. Both polytheonamides A and B are incorporated into the lipid bilayer and conducted monovalent cations as does bacterial linear peptide gramicidin A. The channel formed by polytheonamides showed open and close state. The mechanism of this character needs further study.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Generation of metal-carbene species without using diazo-comoounds and its synthetic application
  • 批准号:
    15K13686
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.58万
  • 财政年份:
    2015
  • 负责人:
    MATSUNAGA Shigeki
  • 依托单位:
Asymmetric C-H Bond Functionalization with Heterodinuclear Asymmetric Catalysts
Innovative Molecular Transformation and Drug Lead Development Based on Fine Design of Multinuclear Catalysis
  • 批准号:
    23689002
  • 项目类别:
    Grant-in-Aid for Young Scientists (A)
  • 资助金额:
    $17.64万
  • 财政年份:
    2011
  • 负责人:
    MATSUNAGA Shigeki
  • 依托单位:
Search for anti-malaria agents from marine organisms
  • 批准号:
    22658065
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.25万
  • 财政年份:
    2010
  • 负责人:
    MATSUNAGA Shigeki
  • 依托单位:
国内基金
海外基金
CircSLTM及其编码多肽SLTM-99aa通过SAFB介导的mRNA剪接重塑在胃癌发生发展中的分子机制及其临床价值研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    胡柯峰
  • 依托单位:
多囊卵巢综合征中甲酰肽受体2调控小胶质细胞代谢重编程导致GnRH神经元过度激活及HPO轴异常的病理机制研究
  • 批准号:
    82370797
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陶弢
  • 依托单位:
Peptide YY调控Hippo/YAP通路促进皮肤组织创面愈合的机制研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    王晓
  • 依托单位:
靶向促黏多肽R-Peptide对iPSCs来源肝脏类器官培养体系的优化及机制研究
  • 批准号:
    32160230
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    36.00万元
  • 批准年份:
    2021
  • 负责人:
    姚佳
  • 依托单位: